PBMs are putting weight loss drugs, including Wegovy and Zepbound, on their national formularies, but coverage by plans is ...

A medical expert in infertility discusses how best practices in communicating benefits for fertility treatments and assisted reproductive technology (ART) programs involve clear, concise and ...

Jeffrey Dunn, Pharm.D., MBA, discusses how social determinants of health and population health factors are integrated into decision-making processes for fertility treatments and assisted reproductive ...

Promising Results Reported in Early-Phase Gene Therapy Trials for Two Types of Inherited Blindness ...

The IQVIA analysis finds that the impact of drug price negotiation on patients’ out-of-pocket spending could also be smaller ...

One area of interest is whether ketogenic diets, which are high in fat and low in carbohydrates, might be helpful to people ...

In an effort to promote research that would help fill this gap, the National Multiple Sclerosis Society has dedicated $4.6 ...

Promising Results Reported in Early-Phase Gene Therapy Trials for Two Types of Inherited Blindness ...

The 2024 increase is the same as last year's increase for family coverage. The foundation’s annual survey of employer health ...

Bayer announced today that the FDA has accepted their new drug application (NDA) for menopause drug, elinzanetant, to treat ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

Studies measuring patient preference stacked up in subcutaneous administration’s favor, according to a recently published ...